Across TCGA pan-cancer cohorts, RPS2P36 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS2P36’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RPS2P36 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS2P36 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

KIRP, KIRC, and THCA are the cancer types where RPS2P36 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS2P36 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.134	<.001	7	view →
KIRC	All	II,III,IV	+0.117	<.001	7	view →
THCA	All	All	−0.067	.001	6	view →
STAD	All	All	+0.178	.010	4	view →
LUSC	All	All	−0.090	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPS2P36 RNA expression & survival · all RPS2P36 data types